mankind
perman
threat
novel
pathogen
qualifi
emerg
review
receptor
mode
entri
three
emerg
zoonot
virus
respons
rare
deadli
diseas
whose
natur
reservoir
bat
sever
acut
respiratori
syndrom
coronaviru
sarscov
hendra
hev
nipah
niv
ebola
ebov
marburg
marv
virus
sarscov
kb
posit
rna
genom
crownlik
shape
typic
coronavida
regular
array
viral
spike
glycoprotein
trimer
constitut
viral
envelop
mediat
bind
cellular
receptor
angiotensin
convert
enzym
ensur
viralcel
membran
fusion
allow
viru
entri
ectometalloproteas
monocarboxypeptidas
activ
cleav
vasoconstrictor
angiotensin
ii
octapeptid
vasodilat
heptapeptid
protect
heart
lung
kidney
deleteri
vasoconstrict
prevent
onset
acut
respiratori
distress
syndrom
tissu
distribut
pneumocyt
ii
lung
epithelium
progenitor
cell
small
intestin
enterocyt
kidney
heart
cardiomyocyt
endothelium
mostli
correl
known
replic
site
sarscov
could
explain
poor
lung
repair
follow
sar
infect
ectopeptidas
type
ii
transmembran
proteas
serin
subfamili
member
recent
identifi
companion
molecul
detect
epithelium
small
intestin
respiratori
tract
major
cell
target
sarscov
endothelium
refractori
sarscov
infect
physic
interact
protein
get
cleav
allow
phand
cathepsinindepend
effici
entri
sarscov
cleav
protein
site
distinct
ascrib
trypsin
cathepsin
l
upon
contact
protein
also
cleav
express
oppos
membran
sarscov
complex
induc
intercellular
fusion
howev
newli
express
protein
escap
cleavag
allow
product
virion
decor
uncleav
possibl
tripartit
associ
prevent
intracellularli
present
model
viru
entri
predict
follow
figur
sarscov
protein
bind
receptor
via
concav
region
receptor
bind
site
rbd
cradl
nm
outer
surfac
ntermin
lobe
ace
peptidas
domain
outsid
enzymat
site
activ
cleav
protein
fusioncompet
homodim
immedi
undergo
typic
class
fusion
protein
structur
chang
permit
viral
envelop
fuse
plasma
membran
heterodim
probabl
unstabl
incorpor
infecti
viru
particl
moreov
activ
possibl
tnfa
convert
enzym
concomitantli
cleav
result
massiv
shed
ectodomain
probabl
due
amplif
constitut
pathway
shed
requir
sarscov
entri
probabl
respons
associ
major
lung
failur
inde
solubl
induc
shed
worsen
clinic
sign
sar
human
accord
viru
strain
divers
affin
correl
efficaci
viru
entri
level
cleavag
intens
patholog
furthermor
highest
affin
associ
interhuman
transmiss
figur
antibodi
target
bind
site
strongli
inhibit
viral
infect
correl
affin
sarscov
pathogen
extend
host
rang
mammal
speci
except
bat
determin
whether
particular
protein
act
receptor
sarscov
includ
among
bat
niv
hev
constitut
henipaviru
genu
paramyxovirida
famili
respons
fatal
respiratori
neurolog
diseas
nonseg
neg
strand
rna
genom
code
two
envelop
glycoprotein
fusion
protein
f
synthes
precursor
matur
function
heterodim
cathepsin
l
via
clathrinmedi
recycl
endosom
pathway
attach
protein
g
tetram
consist
two
disulfid
bridg
dimer
like
morbilliviru
h
parainfluenza
hn
protein
ctermin
globular
head
fold
six
bsheet
blade
propel
surmount
stalk
transmembran
region
cytosol
tail
sugarfre
dimer
interfac
viru
entri
conserv
two
head
rotat
rel
henipaviru
g
measl
viru
h
hn
respect
buri
area
nm
nivg
hevg
correl
effici
viru
entri
interestingli
wherea
niv
g
f
induc
fusion
cell
express
niv
preferenti
enter
intern
via
macropinocytosi
though
acid
ph
requir
viru
entri
membran
fusion
inop
cytosol
tail
pdzbind
motif
delet
tyr
mutat
two
motif
recruit
kinas
complex
govern
macropinocytosi
need
macropinocytosi
fusion
machineri
oper
cell
surfac
puzzl
macropinocytosi
occur
rapidli
upon
contact
could
faster
fusion
step
macropinocytosi
inhibitor
would
expect
prevent
viru
entri
sever
hypothes
propos
fusion
requir
specif
ca
andor
na
ionic
environ
document
semliki
forest
viru
ii
niv
replic
requir
specif
condit
cytoplasm
induc
contact
iii
nucleocapsid
need
reach
particular
cytoplasm
locat
deeper
cell
favor
viral
polymeras
activ
latter
would
unpreced
sinc
forc
rerout
viru
normal
enter
fusion
cell
surfac
endocyt
pathway
result
hamper
infect
shown
pseudotyp
measl
viru
lentivector
filovirus
elus
receptor
filovirida
ebov
marv
caus
sever
hemorrhag
fever
septiclik
shock
human
nonseg
neg
rna
genom
code
envelop
glycoprotein
gp
ensur
attach
still
elus
cellular
receptor
membran
fusion
gp
cleav
furinlik
proteas
matur
heterodim
curious
mutat
furincleavag
site
abolish
gpmediat
viru
entri
due
altern
cleavag
gp
heavili
glycosyl
sugar
moieti
recogn
lesctin
dcsignr
lectin
enhanc
mediat
infect
high
glycan
content
shield
mhc
class
bintegrin
antibodi
recognit
find
explain
previous
report
appar
downregul
latter
cellular
receptor
glycoprotein
natur
predict
basi
satur
bind
solubl
gp
loss
bind
proteas
period
tunicamycin
treatment
infect
anim
viru
dissemin
mani
tissu
ebov
receptor
stock
transgolgi
network
membran
cell
type
includ
nonpermiss
b
lymphocyt
export
cell
surfac
upon
cell
adhes
intern
via
microtubuledepend
actindepend
pathway
respect
ebov
marv
gp
crosscompet
bind
suggest
use
common
receptor
howev
key
lysin
posit
defin
receptor
bind
region
rbr
ebov
conserv
marv
structur
solubl
trimer
form
reveal
chalic
form
line
rbr
fusion
compet
trimer
cradl
chalic
stem
intern
fusion
peptid
flank
two
bsheet
rbr
mostli
shield
glycan
cap
mucinlik
domain
cleavag
cathepsin
strongli
enhanc
bind
cell
surfac
howev
lower
ph
neither
allow
ebov
entri
cell
surfac
cellcel
fusion
mucindelet
gpreceptor
interact
stabl
acid
ph
effect
ebov
mostli
enter
macropinocytosi
requir
lipid
raft
na
h
exchang
pak
rhoc
gtpase
vacuol
closur
protein
ctermin
bind
protein
ctbpbar
constitut
macropinocytosi
dendrit
cell
macrophag
fit
permiss
ebov
infect
activ
enhanc
macropinocytosi
ebov
entri
although
latter
may
mediat
serum
recent
report
mediat
nonspecif
entri
sever
envelop
virus
ebov
marv
entri
process
last
h
schemat
follow
figur
firstli
ebov
attach
cell
via
interact
dcsignr
andor
lecstin
ii
immedi
intern
constitut
andor
viruscontactinduc
macropinocytosi
iii
min
endocyt
traffick
ebov
reach
late
endosom
compart
iv
resid
cathepsin
b
cleav
mucinlik
domain
v
expos
rbr
put
receptor
recruit
vi
late
phdepend
activ
step
mucindelet
complex
trigger
fusion
activ
possibl
via
reduct
disulfid
bridg
conclus
sever
lesson
taken
home
two
paper
demonstr
intracellular
pool
rbr
bind
protein
ebov
export
cell
surfac
upon
cell
adhes
includ
lymphocyt
refractori
ebov
infect
probabl
poorli
abl
prime
gp
